2016 SGO临床实践指南：新辅助化疗治疗新诊断晚期卵巢癌
发布日期：
2016-09-20
英文标题：
Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline.
出处：
Gynecol Oncol. 2016 Oct;143(1):3-15.
摘要：
2016年9月，美国妇科肿瘤学会(SGO)发布了新辅助化疗治疗新诊断晚期卵巢癌临床实践指南，主要目的是为新辅助化疗和间隔肿瘤细胞减灭术治疗ⅢC或IV期上皮性卵巢癌患者提供临床指导。
展开部分内容仅可在
临床指南app 查看下载
阅读免费指南
发送到邮箱
收藏
分享
评论
提交评论
/ 没有更多了 /
上传者信息
踩蘑菇的小姑娘~
于2016-09-28上传
编者信息
美国妇科肿瘤学会
The Society of Gynecologic Oncology (SGO) is the premier medical specialty society for health care professionals trained in the comprehensive management of gynecologic cancers. As a 501(c)(6) organization, the SGO contributes to the advancement of women’s cancer care by encouraging research, providing education, raising standards of practice, advocating for patients and members and collaborating with other domestic and international organizations.
置顶
